Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Considering Workshop On Intellectual Property/Antitrust Drug Issues

Executive Summary

The Federal Trade Commission staff is considering a workshop on pharmaceutical antitrust and intellectual property issues for later this year.

You may also be interested in...



FTC Patent/Competition Hearings To Include Discussion Of “Patent Thicket”

The increase in patents issued in the U.S. will be one topic of discussion during hearings on the relationship between intellectual property and competition sponsored by the Federal Trade Commission and the Justice Department Antitrust Division

FTC Patent/Competition Hearings To Include Discussion Of “Patent Thicket”

The increase in patents issued in the U.S. will be one topic of discussion during hearings on the relationship between intellectual property and competition sponsored by the Federal Trade Commission and the Justice Department Antitrust Division

FTC Spadework For Waxman/Hatch Reform Includes Survey, Patent Forum

The Federal Trade Commission is working on a schedule to collect background material for Congress on Waxman/Hatch reform by the beginning of 2002.

UsernamePublicRestriction

Register

LL1134561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel